Harvard Apparatus Regenerative Technology, Inc.: revenue

What this measure means

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Exact concept: us-gaap:Revenues. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2012-01-01 to 2021-12-31. The SEC response was captured on 2026-09-20.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• Harvard Apparatus Regenerative Technology, Inc.: total assets
• Harvard Apparatus Regenerative Technology, Inc.: total liabilities
• Harvard Apparatus Regenerative Technology, Inc.: stockholders equity
• Harvard Apparatus Regenerative Technology, Inc.: cash and cash equivalents
• Harvard Apparatus Regenerative Technology, Inc.: net income or loss
• Harvard Apparatus Regenerative Technology, Inc.: operating cash flow
• Harvard Apparatus Regenerative Technology, Inc.: capital expenditure payments
• Harvard Apparatus Regenerative Technology, Inc.: contract revenue excluding tax
• Harvard Apparatus Regenerative Technology, Inc.: financing cash flow
• Harvard Apparatus Regenerative Technology, Inc.: investing cash flow
• Harvard Apparatus Regenerative Technology, Inc.: retained earnings or deficit
• Harvard Apparatus Regenerative Technology, Inc.: basic weighted-average shares
• Harvard Apparatus Regenerative Technology, Inc.: diluted weighted-average shares
• Harvard Apparatus Regenerative Technology, Inc.: basic earnings per share
• Harvard Apparatus Regenerative Technology, Inc.: diluted earnings per share
• Harvard Apparatus Regenerative Technology, Inc.: net property, plant and equipment
• Harvard Apparatus Regenerative Technology, Inc.: share-based compensation expense
• Harvard Apparatus Regenerative Technology, Inc.: operating income or loss
• Harvard Apparatus Regenerative Technology, Inc.: current assets
• Harvard Apparatus Regenerative Technology, Inc.: current liabilities
• Harvard Apparatus Regenerative Technology, Inc.: current accounts payable
• Harvard Apparatus Regenerative Technology, Inc.: net current accounts receivable
• Harvard Apparatus Regenerative Technology, Inc.: common-stock repurchase payments
• Harvard Apparatus Regenerative Technology, Inc.: operating expenses
• Harvard Apparatus Regenerative Technology, Inc.: net inventory
• Harvard Apparatus Regenerative Technology, Inc.: gross profit
• Harvard Apparatus Regenerative Technology, Inc.: cost of revenue
• Harvard Apparatus Regenerative Technology, Inc.: selling, general and administrative expense
• Harvard Apparatus Regenerative Technology, Inc.: research and development expense

Inspect the source

Entity

Harvard Apparatus Regenerative Technology, Inc. / CIK 0001563665

Captured

2026-09-20T09:20:15.929Z

SEC response SHA-256

e9daa8cb46b85f929c860a045510b8e1f3e399a065eda3e159fd4dcb12459b1e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001563665.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))